Cargando…
A modest proposal for a new way forward for clinical research: Involve insurance companies
Is it time for medical insurance companies to organize and fund clinical research that evaluates the role of new treatments (drugs or device‐based therapies) in the context of existing clinical paradigms for common diseases?
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305258/ https://www.ncbi.nlm.nih.gov/pubmed/35061938 http://dx.doi.org/10.1002/alr.22980 |
| Sumario: | Is it time for medical insurance companies to organize and fund clinical research that evaluates the role of new treatments (drugs or device‐based therapies) in the context of existing clinical paradigms for common diseases? |
|---|